Emanuela Tafi

No ORCID on file · 6 papers in corpus · active 2014-2017

Study types

  • article 2
  • other 2
  • review 2

Condition tags

  • mesh:D004715 6
  • endometriosis 5
  • bowel_endometriosis 2
  • dysmenorrhea 1
  • endometrioma 1
article 2017
Impact of large ovarian endometriomas on the response to superovulation for in vitro fertilization: A retrospective study
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2017.04.003
article 2017
Spontaneous fertility after expectant or surgical management of rectovaginal endometriosis in women with or without ovarian endometrioma: a retrospective analysis
Fertility and sterility ·doi:10.1016/j.fertnstert.2017.02.106
other 2017
Symptomatic endometriosis of the posterior cul-de-sac is associated with impaired sleep quality, excessive daytime sleepiness and insomnia: a case-control study
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2015.11.026

OBJECTIVE: To assess the impact of endometriosis of the posterior cul-de-sac on quality of sleep, average daytime sleepiness and insomnia. STUDY DESIGN: This age-matched case-control study was conducted in a tertiary referral centre for th…

review 2015
Advances in pharmacotherapy for treating endometriosis
Expert opinion on pharmacotherapy ·doi:10.1517/14656566.2015.1085510

INTRODUCTION: Endometriosis is an estrogen-dependent chronic disease requiring long-term therapy. Therefore, the choice of medical treatment should be based on efficacy, preference of patients, incidence and severity of adverse effects and …

other 2014
Desogestrel-only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open-label comparative study
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.12326

OBJECTIVE: To compare the efficacy of two hormonal therapies in treating symptoms caused by bowel endometriosis. DESIGN: Patient preference study. SETTING: University hospital. POPULATION: A total of 143 women with rectovaginal endometri…

review 2014
Dienogest in the treatment of endometriosis
Expert opinion on pharmacotherapy ·doi:10.1517/14656566.2014.943734

INTRODUCTION: Dienogest (DNG) is an oral progestin, derivative of 19-nortestosterone, that has recently been introduced for the treatment of endometriosis. AREAS COVERED: This review examines the clinical efficacy, safety and tolerability o…